13F filing recap · Q2 2023
What did Matrix Asset Advisors buy in Q2 2023?
Reported stock-position changes between this filing and the previous one.
Stock value
$725.68M
Positions
96
Estimated turnover
6.5%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
New positions
PFEPfizer Inc.$4.16Mreported value+113.5K sharesUNHUnitedHealth Group Incorporated$3.39Mreported value+7.1K sharesVTIVanguard Index Funds$2.31Mreported value+10.5K sharesVXFVanguard Index Funds$791.0Kreported value+5.3K sharesNVDANvidia Corp$242.4Kreported value+573 sharesCLColgate-Palmolive Company$204.2Kreported value+2.6K shares